Koller, E., Cross, J., Doraiswamy, P. and Malozowski, S. (2003) Pancreatitis associated with atypical antipsychotics: From the food and drug administration’s medwatch surveillance system and published reports. Pharmacotherapy, 23, 1123-1130. doi:10.1592/phco.23.10.1123.32759

has been cited by the following article:

• TITLE: Case report: Olanzapine-induced acute pancreatitis and new diabetes mellitus

  AUTHORS: Erik Monasterio, Ruchi Bhalla, Andrew McKean

  KEYWORDS: Case Report; Olanzapine; Pancreatitis; Diabetes Mellitus

  JOURNAL NAME: Open Journal of Psychiatry, Vol.2 No.2, April 18, 2012

  ABSTRACT: The aim of this case study is to review the literature and report the first published case of olanzapine-induced acute pancreatitis in New Zealand. A case report of acute pancreatitis with new onset diabetes mellitus secondary to olanzapine in a 42-year-old male, in the absence of medical risk factors is reported. Eleven previous case reports of olanzapine induced acute-pancreatitis were identified in the literature. A 42-year-old male was diagnosed with acute pancreatitis and new diabetes mellitus induced by olanzapine. Although rare, pancreatitis is associated with use of some atypical antipsychotic medications. It is important for prescribers to be aware of this potentially fatal side effect. In addition to this, we are highlighting the well documented evidence of metabolic disruption associated with olanzapine.